We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. Generics Must Expand 'Value Chain' to Compete Globally
U.S. Generics Must Expand 'Value Chain' to Compete Globally
February 21, 2006
U.S. generic drug firms need to diversify their companies to include more segments of the pharmaceutical manufacturing process if they hope to compete globally, said one pharmaceutical finance expert at a recent industry conference.